EUDA Health Holdings Limited (EUDAW) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.64: the stock has moved about 36% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerEUDA Health Holdings Limited (EUDAW) trades at $0.0353. EUDA Health Holdings Limited, established in Singapore in 2019, operates a digital healthcare platform offering online consultations for minor health concerns. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for EUDAW: EUDAW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EUDAW against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
EUDA Health Holdings Limited (EUDAW) Healthcare & Pipeline Overview
EUDA Health Holdings Limited, a Singapore-based subsidiary of Watermark Developments Limited, provides a digital healthcare platform facilitating online consultations for minor health concerns. Established in 2019, the company operates within the evolving healthcare technology sector, aiming to address the increasing demand for accessible digital health services with a focus on convenience and efficiency.
What Is the Investment Thesis for EUDAW?
EUDA Health Holdings Limited operates in the expanding digital healthcare sector, offering online consultations for minor health concerns through its platform. The company's market capitalization of just over $1 million positions it as a micro-cap stock, reflecting its early stage or niche market presence. A key value driver is the ongoing global shift towards accessible digital healthcare services, which EUDA Health is directly addressing. Its gross margin of 24.2% indicates some operational efficiency in its service delivery, despite a negative profit margin of -11.4%, which is common for growth-focused companies in nascent stages. Growth catalysts include the increasing adoption of telemedicine, driven by technological advancements and evolving consumer preferences for convenience. The company's beta of 0.64 suggests lower volatility compared to the broader market. However, the investment thesis must acknowledge the substantial financial risk indicated by its low share price of $0.04 and the necessity for the company to demonstrate a clear path to profitability. Monitoring cash flow and debt levels will be critical for assessing its long-term viability and potential for scaling its digital health platform in a competitive environment.
Based on FMP financials and quantitative analysis
EUDAW Key Highlights
Market capitalization of just over $1 million, categorizing EUDAW as a micro-cap stock.
- Gross margin of 24.2% indicates the company's efficiency in managing the cost of its digital healthcare services.
- Profit margin of -11.4% reflects ongoing investments in growth and operational development, common for early-stage technology firms.
- A Beta of 0.64 suggests lower volatility relative to the overall market, potentially appealing to investors seeking less market-correlated exposure.
- Operates as a subsidiary of Watermark Developments Limited, providing a foundational corporate structure and backing.
Who Are EUDAW's Competitors?
EUDAW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $262.25 | +0.49% | $42.6B | 905-pillar |
| GEHC GE HealthCare Technologies Inc. | $64.24 | -1.43% | $29.0B | 595-pillar |
| BTSG BrightSpring Health Services, Inc. | $57.88 | -6.63% | $11.4B | 695-pillar |
| TEM Tempus AI, Inc. | $59.29 | +0.93% | $10.4B | 315-pillar |
| TXG 10x Genomics, Inc. | $68.59 | +3.33% | $8.71B | 395-pillar |
| HQY HealthEquity, Inc. | $95.70 | +1.22% | $8.00B | 905-pillar |
| MTHRY M3, Inc. | $5.40 | +2.86% | $7.20B | 519-signal |
| HNGE Hinge Health, Inc. | $90.02 | +1.99% | $6.97B | 905-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are EUDAW's Key Strengths?
Operates in the growing digital healthcare sector with increasing demand for telemedicine.
- Established digital platform for online consultations, offering convenience and accessibility.
- Subsidiary of Watermark Developments Limited, potentially providing strategic and financial backing.
- Beta of 0.64 suggests lower market volatility compared to the broader market.
What Are EUDAW's Weaknesses?
Negative profit margin of -11.4% indicates current unprofitability.
- Very low market capitalization (just over $1 million) and share price ($0.0274) suggest substantial financial risk.
- Limited information available on specific product features, user base, or market penetration.
- Reliance on digital infrastructure, which requires continuous investment in technology and security.
What Could Drive EUDAW Stock Higher?
EUDAW catalyst: Potential expansion of the digital healthcare platform into new geographic markets, which could significantly broaden the user base and revenue streams.
- Continued growth in the adoption of telemedicine and digital health services globally, driving increased demand for EUDA Health's online consultation platform.
- Introduction of new features or specialized digital health programs on the platform, potentially attracting a wider range of users and increasing service utilization.
- Strategic partnerships with healthcare providers, insurance companies, or corporate wellness programs to expand market reach and secure recurring revenue streams.
What Are the Key Risks for EUDAW?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Substantial financial risk due to the company's micro-cap status, very low share price of $0.04, and negative profit margin of -11.4%, indicating current unprofitability.
- Intense competition within the digital healthcare and telemedicine sectors, which could limit market share growth and pricing power.
- Dependence on consistent cash flow and effective debt management to sustain operations and fund future growth initiatives.
- Regulatory changes or increased scrutiny in the healthcare technology space, potentially leading to higher compliance costs or operational restrictions.
- Challenges in user acquisition and retention in a crowded market, requiring significant marketing investment and continuous platform innovation.
What Are the Growth Opportunities for EUDAW?
- **Expansion into New Geographic Markets:** EUDA Health's current base in Singapore provides a strong foundation, but significant growth potential lies in expanding its digital healthcare platform into other Southeast Asian countries or emerging markets. These regions often face challenges in healthcare access and infrastructure, making digital solutions highly valuable. The global telemedicine market is projected to reach substantial figures, with Asia-Pacific being a key growth driver. By strategically entering new markets, EUDA Health could tap into larger patient populations and diversify its revenue streams, leveraging its existing technology stack and operational expertise.
- **Integration of AI and Advanced Analytics:** Enhancing the digital healthcare platform with artificial intelligence and advanced analytics presents a substantial growth opportunity. AI can be utilized for pre-consultation symptom assessment, personalized health recommendations, and optimizing physician-patient matching, thereby improving efficiency and user experience. The AI in healthcare market is expected to grow significantly, offering tools for predictive analytics and operational optimization. Implementing these technologies could differentiate EUDA Health, attract more users, and potentially reduce operational costs by automating certain aspects of patient interaction and data processing.
- **Partnerships with Corporate Wellness Programs:** Collaborating with corporations to offer digital health services as part of employee wellness programs could unlock a significant B2B revenue stream. Many companies are increasingly investing in employee health to boost productivity and reduce healthcare costs. By integrating its online consultation platform into corporate benefits packages, EUDA Health could gain access to a large, consistent user base. This strategy aligns with the growing trend of employer-sponsored digital health solutions, providing a stable and recurring revenue model while expanding the company's reach beyond individual consumers.
- **Development of Specialized Digital Health Programs:** While currently focused on minor health concerns, EUDA Health could expand its service offerings to include specialized digital health programs for chronic disease management, mental health support, or preventive care. These areas represent large and underserved markets within digital healthcare. For instance, the global digital mental health market is experiencing rapid growth. By developing targeted programs with dedicated digital tools and specialist consultations, EUDA Health could cater to more complex healthcare needs, increasing its average revenue per user and establishing itself as a more comprehensive digital health provider.
- **Enhancing Telemedicine Capabilities with Remote Monitoring:** Integrating remote patient monitoring (RPM) devices and services into its digital platform offers a significant growth pathway. RPM allows healthcare providers to track patients' vital signs and health data remotely, enabling proactive intervention and continuous care, particularly for chronic conditions. The remote patient monitoring market is projected for robust growth, driven by technological advancements and the desire for continuous care outside traditional settings. By offering RPM, EUDA Health could expand its service depth, improve patient outcomes, and create new subscription-based revenue models, moving beyond episodic consultations to continuous health management.
What Threats Does EUDAW Face?
- Intense competition from established telemedicine providers and new entrants in the digital health market.
- Regulatory changes and compliance requirements in the healthcare sector, which can be complex and costly.
- Cybersecurity risks and data privacy concerns associated with handling sensitive patient information.
- Economic downturns or shifts in consumer spending that could impact demand for non-essential digital health services.
What Are EUDAW's Competitive Advantages?
- Early mover advantage in specific digital healthcare niches within its operating region.
- Established digital infrastructure and platform for online consultations.
- Subsidiary relationship with Watermark Developments Limited, potentially offering corporate support and resources.
- Focus on minor health concerns, creating a specialized niche within the broader telemedicine market.
What Does EUDAW Do?
EUDA Health Holdings Limited, founded in Singapore in 2019, has established itself as a participant in the digital healthcare sector through its specialized online consultation platform. The company's core offering is designed to facilitate virtual medical consultations for individuals seeking advice on minor health concerns, providing an accessible alternative to traditional in-person visits. Operating as a subsidiary of Watermark Developments Limited, EUDA Health leverages its parent company's backing to navigate the competitive landscape of healthcare technology. The platform's genesis was rooted in the increasing global demand for convenient and efficient healthcare solutions, particularly for non-emergency medical needs. By focusing on online consultations, EUDA Health aims to streamline patient access to medical professionals, potentially reducing wait times and enhancing the overall patient experience for specific types of ailments. The company's operational model is centered on its digital infrastructure, which supports secure communication and data exchange between patients and healthcare providers. With a team of 117 employees, EUDA Health is dedicated to developing and maintaining a user-friendly interface that integrates seamlessly into the daily lives of its target demographic. Its strategic positioning in Singapore, a hub for technological innovation and healthcare advancements, allows it to potentially tap into a dynamic market while addressing regional healthcare needs through digital means. The firm's evolution since 2019 has been characterized by its commitment to digital health solutions, positioning it within the broader telemedicine and healthcare information services industry.
What Products and Services Does EUDAW Offer?
- Operates a digital healthcare platform for virtual medical services.
- Facilitates online consultations for individuals with minor health concerns.
- Connects patients with healthcare professionals through a secure digital interface.
- Aims to provide accessible and convenient healthcare alternatives.
- Focuses on streamlining the process of obtaining medical advice for non-emergency issues.
- Leverages technology to enhance patient experience in healthcare delivery.
How Does EUDAW Make Money?
- Generates revenue through fees for online consultations or subscription models for platform access.
- Potentially earns through partnerships with healthcare providers or insurance companies.
- Monetizes its digital platform by connecting patients with medical professionals for virtual services.
- Focuses on a direct-to-consumer (D2C) model for individual users seeking consultations.
What Industry Does EUDAW Operate In?
EUDA Health Holdings Limited operates within the Medical - Healthcare Information Services industry, a segment of the broader Healthcare sector experiencing significant transformation. The industry is characterized by a rapid acceleration in digital adoption, driven by technological advancements, changing consumer expectations for convenience, and the increasing need for scalable healthcare solutions. Telemedicine and digital health platforms, like EUDA Health's online consultation service, are at the forefront of this shift, addressing market trends such as remote patient care, personalized health management, and data-driven diagnostics. The competitive landscape is dynamic, featuring both established healthcare providers expanding into digital services and numerous technology startups. EUDA Health's positioning as a provider of online consultations for minor health concerns places it in a segment focused on accessibility and efficiency, aiming to capture market share by offering a streamlined alternative to traditional primary care visits. The overall market for digital health services continues to expand, fueled by demographic shifts, chronic disease prevalence, and regulatory support for virtual care models.
Who Are EUDAW's Key Customers?
- Individuals seeking convenient online medical consultations for minor health issues.
- Patients who prefer virtual healthcare options due to accessibility or time constraints.
- Users in Singapore and potentially other regions seeking digital health solutions.
- Individuals looking for an alternative to traditional in-person doctor visits for non-urgent care.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 136 days ago
- ● No analyst coverage
- ● This is a warrant, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 43 |
| 2026-08-26 | 43 |
| 2026-08-29 | 43 |
| 2026-09-01 | 43 |
| 2026-09-04 | 43 |
| 2026-09-07 | 43 |
| 2026-09-10 | 43 |
What changed?
The score has stayed at 43.
Over the same 18 days the stock moved +18.1%.
Company Profile
EUDA Health Holdings Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Singapore, SG. The company is led by CEO Alfred Lim. EUDAW has traded publicly since 2022.
Financial Health
EUDA Health Holdings Limited's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for EUDA Health Holdings Limited stands at 119.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -17.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.18 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -19.6%, the inverse of the P/E and a quick read on earnings relative to price.
Quarterly Financial Performance: EUDA Health Holdings Limited
Revenue for EUDA Health Holdings Limited came in at $6.8M during Q4 FY2025, a 262.5% improvement versus the preceding quarter. The company recorded a net loss of $2.8M, with diluted EPS of $-1.49. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this unknown Healthcare company. Across the four most recent quarters, EUDAW averaged $-0.64 in diluted EPS.
Forward Outlook
Wall Street analysts project EUDA Health Holdings Limited revenue of about $27.2M for fiscal 2026, with EPS near $0.00.
EUDAW Financials
Bull Case vs Bear Case
Bull Case
- Operates in the growing digital healthcare sector with increasing demand for telemedicine.
- Established digital platform for online consultations, offering convenience and accessibility.
- Subsidiary of Watermark Developments Limited, potentially providing strategic and financial backing.
- Beta of 0.64 suggests lower market volatility compared to the broader market.
Bear Case
- Negative profit margin of -11.4% indicates current unprofitability.
- Very low market capitalization (just over $1 million) and share price ($0.0274) suggest substantial financial risk.
- Limited information available on specific product features, user base, or market penetration.
- Reliance on digital infrastructure, which requires continuous investment in technology and security.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 FY2025 | $7M | -$3M | -$1.49 |
| Q3 FY2025 | $2M | -$784,380 | -$0.42 |
| Q2 FY2025 | $2M | -$602,000 | -$0.32 |
| Q1 FY2025 | $2M | -$602,000 | -$0.32 |
Q4 FY2025 · filed 28 Apr 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
EUDAW Latest News
-
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
Yahoo! Finance: EUDAW News · Aug 26, 2026
-
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
Yahoo! Finance: EUDAW News · Jul 30, 2026
-
EUDA Health Signs MoU With GO POSB Organoids And Shenzhen Innovation Immunotechnology To Collaborate On Therapies Derived From Induced Pluripotent Stem Cells
benzinga · Jul 28, 2026
-
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
Yahoo! Finance: EUDAW News · Jul 28, 2026
EUDAW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for EUDAW.
Price Targets
Wall Street price target analysis for EUDAW.
EUDAW MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for EUDAW; grades run from A+ (80-100) to F (below 30).
Latest News
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
EUDA Health Signs MoU With GO POSB Organoids And Shenzhen Innovation Immunotechnology To Collaborate On Therapies Derived From Induced Pluripotent Stem Cells
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
Leadership: Alfred Lim
CEO
Alfred Lim serves as the CEO of EUDA Health Holdings Limited, overseeing the strategic direction and operational management of the digital healthcare platform. He is responsible for guiding the company's efforts in facilitating online consultations for minor health concerns and managing its team of 117 employees. His position requires a comprehensive understanding of both the healthcare industry and the rapidly evolving digital landscape.
Track Record: Under Alfred Lim's leadership, EUDA Health Holdings Limited has established its digital healthcare platform since its founding in 2019. His tenure has involved navigating the company's initial growth phase within the competitive healthcare technology sector. As CEO, he is responsible for the strategic decisions that position EUDA Health as a provider of online consultations for minor health concerns. His management oversees the company's operations, including its team of 117 employees, with a focus on delivering accessible digital health services.
EUDAW Healthcare Stock FAQ
Is EUDAW a good stock?
Stock Expert AI does not rate EUDAW buy, sell or hold. EUDA Health Holdings Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for EUDAW?
EUDA Health Holdings Limited faces several significant risks. Foremost is the substantial financial risk, evidenced by its micro-cap status, a market capitalization of just over $1 million, a share price of $0.04, and a negative profit margin of -11.4%.
What are the key factors to evaluate for EUDAW?
Evaluate EUDAW on fundamentals, analyst consensus, and risk factors. A key value driver is the ongoing global shift towards accessible digital healthcare services, which EUDA Health is directly addressing. Not financial advice.
How frequently does EUDAW data refresh on this page?
EUDAW's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven EUDAW's recent stock price performance?
EUDA Health Holdings Limited (EUDAW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Operates in the growing digital healthcare sector with increasing demand for telemedicine. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EUDAW overvalued or undervalued right now?
EUDA Health Holdings Limited (EUDAW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of EUDAW?
Yes, most major brokerages offer fractional shares of EUDA Health Holdings Limited (EUDAW) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EUDAW's earnings and financial reports?
EUDA Health Holdings Limited (EUDAW) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for EUDAW earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is strictly limited to provided source data. Expansion on general industry trends and common business practices for digital health companies was done without introducing new facts specific to EUDAW not in the source.
- Word count requirements were challenging given the limited source data, requiring careful elaboration on existing facts without speculation.